Company Filing History:
2 out of 2 
1 out of 15,528 
1 out of 2,106 
Years Active: 1999-2004
Title: Pedro E Leon: Innovator in Genetic Research
Introduction
Pedro E Leon is a notable inventor based in San Jose, Costa Rica. He has made significant contributions to the field of genetic research, particularly in understanding bipolar mood disorders and the modulation of actin filaments. With a total of 4 patents, his work has implications for both diagnosis and treatment in the biopharmaceutical industry.
Latest Patents
One of his latest patents focuses on methods for treating bipolar mood disorder associated with markers on chromosome 18p. This invention provides a groundbreaking approach to detecting susceptibility loci for bipolar mood disorder by analyzing DNA samples for specific polymorphisms. It offers strong evidence of a susceptibility gene located in the terminal 5 cM region of chromosome 18, which can aid in the genetic diagnosis and treatment of individuals with bipolar mood disorder.
Another significant patent involves modulators of actin. This invention presents methods and compositions that stabilize actin filaments, which are crucial for various cellular functions. The compositions may include polypeptide moieties derived from a novel human diaphanous polypeptide, as well as nucleic acid moieties from a novel human diaphanous gene. This work has potential applications in diagnosis, therapy, and the biopharmaceutical industry.
Career Highlights
Pedro E Leon has worked at the University of Costa Rica, where he has contributed to advancing research in genetics and biopharmaceuticals. His academic background and research endeavors have positioned him as a key figure in his field.
Collaborations
Throughout his career, Pedro has collaborated with notable individuals such as Nelson B Freimer and Lodewijk Sandkuijl. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Pedro E Leon is a distinguished inventor whose work in genetic research has the potential to transform the understanding and treatment of bipolar mood disorders and actin modulation. His contributions continue to influence the biopharmaceutical industry and enhance the field of genetics.